410 Medical, Inc. — SEC Form D Filing

410 Medical, Inc. filed an SEC Form D on July 15, 2026, reporting $10.32M raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
July 15, 2026
Amount reported
$10.32M
Round stage
Series B+
Industry
Medical Devices
Website
https://410medical.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Clinicians face barriers in quickly and efficiently delivering blood and fluids to critically ill patients, especially those with hemorrhagic shock or life-threatening bleeding.

Solution

The company develops LifeFlow and LifeFlow PLUS, hand-operated, portable fluid and blood infusers designed for the rapid and controlled delivery of resuscitative fluids to critically ill patients.

Why now

Advances in medical technology and a focus on improving emergency care efficiency and patient outcomes are driving demand for faster, more effective intervention tools.

Verdict

Investors backed this round because the company presented a clear, immediate clinical need with a tangible, portable solution. They implicitly bet on broad adoption within critical care environments due to ease of use and demonstrable speed advantages, not on a fundamental disruption of fluidics technology. The upside was limited by the specialized nature of the device and the likelihood of needing strong clinical advocacy to overcome established protocols and incumbent solutions.

Source: SEC EDGAR Form D filing